Biomea Fusion, Inc.

Biomea Fusion is a drug development company working on medicines to treat diabetes and obesity. The company is testing several experimental drugs in clinical trials, which are the studies that test whether new medicines work and are safe for patients. Their main drug candidate, icovamenib, is being tested in Phase II trials for different types of diabetes. They are also developing another experimental drug for obesity treatment that is in earlier-stage testing. The company was founded in 2017 and is based in California.